Gainers

• Cyclerion Therapeutics (NASDAQ:CYCN) stock rose 47.4% to $4.45 during Tuesday's after-market session. The market value of their outstanding shares is at $9.7 million.
• Applied Therapeutics (NASDAQ:APLT) shares rose 11.21% to $0.5. The market value of their outstanding shares is at $68.5 million.
• Rallybio (NASDAQ:RLYB) shares rose 6.29% to $0.62. The market value of their outstanding shares is at $25.4 million.
• SAB Biotherapeutics (NASDAQ:SABS) stock increased by 6.19% to $2.4. The company's market cap stands at $23.0 million.
• AN2 Therapeutics (NASDAQ:ANTX) shares moved upwards by 5.79% to $1.35. The market value of their outstanding shares is at $36.6 million.
• Adaptimmune Therapeutics (NASDAQ:ADAP) stock moved upwards by 5.26% to $0.16. The market value of their outstanding shares is at $44.3 million.

Losers

• Aytu BioPharma (NASDAQ:AYTU) stock decreased by 13.3% to $2.22 during Tuesday's after-market session. The company's market cap stands at $22.3 million. As per the news, the Q4 earnings report came out today.
• Incannex Healthcare (NASDAQ:IXHL) stock declined by 10.66% to $0.6. The company's market cap stands at $38.5 million.
• Soligenix (NASDAQ:SNGX) stock fell 5.65% to $1.84. The market value of their outstanding shares is at $7.6 million.
• Apimeds Pharmaceuticals (AMEX:APUS) stock fell 4.69% to $1.83. The company's market cap stands at $24.6 million.
• Basel Medical Group (NASDAQ:BMGL) shares declined by 4.22% to $1.82. The company's market cap stands at $33.4 million.
• Check-Cap (NASDAQ:CHEK) shares declined by 3.75% to $2.16. The company's market cap stands at $14.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

• No comments yet. Be the first to comment!